JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.13% |
| 2 | Financials | 11.98% |
| 3 | Healthcare | 9.78% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMDX
4476
Insight Molecular Diagnostics
IMDX
$121M
| $181K | ﹤0.01% |
2,289
+2,274
| +15,160% | +$147K |
|
|
ACGN
4477
DELISTED
Aceragen Inc
ACGN
| $181K | ﹤0.01% |
4,173
+659
| +19% | +$31.9K |
|
4478
Banc of California
BANC
$3.11B
| $179K | ﹤0.01% |
12,934
-493
| -4% | -$7.36K |
|
4479
Fortuna Silver Mines
FSM
$3.1B
| $179K | ﹤0.01% |
53,471
-449,131
| -89% | -$1.66M |
|
|
AFT
4480
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
| $179K | ﹤0.01% |
12,090
-26
| -0.2% | -$384 |
|
4481
iShares Core 10+ Year USD Bond ETF
ILTB
$595M
| $178K | ﹤0.01% |
2,842
-130
| -4% | -$7.84K |
|
4482
Vanguard World Funds Extended Duration ETF
EDV
$3.49B
| $177K | ﹤0.01% |
1,489
+814
| +121% | +$92.5K |
|
4483
Natera
NTRA
$44.8B
| $177K | ﹤0.01% |
8,587
-154,168
| -95% | -$2.42M |
|
4484
ProQR Therapeutics
PRQR
$261M
| $177K | ﹤0.01% |
+12,775
| New | +$191K |
|
|
CARO
4485
DELISTED
Carolina Financial Corp.
CARO
| $177K | ﹤0.01% |
5,128
-240
| -4% | -$8.32K |
|
|
FLY
4486
DELISTED
Fly Leasing Limited
FLY
| $177K | ﹤0.01% |
12,788
+9,158
| +252% | +$108K |
|
4487
First Mid Bancshares
FMBH
$1.39B
| $176K | ﹤0.01% |
5,293
-6,705
| -56% | -$227K |
|
4488
State Street Global Allocation ETF
GAL
$316M
| $176K | ﹤0.01% |
4,673
| – | – |
|
4489
Amphastar Pharmaceuticals
AMPH
$858M
| $175K | ﹤0.01% |
8,542
-125,296
| -94% | -$2.81M |
|
|
COOP
4490
DELISTED
Mr. Cooper
COOP
| $174K | ﹤0.01% |
18,154
-853
| -4% | -$11.5K |
|
|
EVM
4491
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
| $174K | ﹤0.01% |
+16,499
| New | +$172K |
|
4492
Nutanix
NTNX
$18.4B
| $174K | ﹤0.01% |
4,625
-2,875,464
| -100% | -$132M |
|
|
MEET
4493
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $174K | ﹤0.01% |
34,571
-206,072
| -86% | -$1.15M |
|
|
BANX
4494
ArrowMark Financial
BANX
$200M
| $173K | ﹤0.01% |
8,045
-10,300
| -56% | -$213K |
|
4495
Daktronics
DAKT
$988M
| $173K | ﹤0.01% |
23,166
+83
| +0.4% | +$643 |
|
4496
CALL
Rigel Pharmaceuticals
RIGL
$762M
| $173K | ﹤0.01% |
6,750
-3,250
| -33% | -$74.3K |
|
|
4497
PUT
Rigel Pharmaceuticals
RIGL
$762M
| $173K | ﹤0.01% |
6,750
-3,250
| -33% | -$74.3K |
|
4498
Veracyte
VCYT
$3.42B
| $173K | ﹤0.01% |
6,903
-69,749
| -91% | -$1.33M |
|
|
PAMT
4499
PAMT Corp
PAMT
$285M
| $173K | ﹤0.01% |
14,104
+3,604
| +34% | +$44.5K |
|
|
APLS
4500
DELISTED
Apellis Pharmaceuticals
APLS
| $172K | ﹤0.01% |
8,811
-414
| -4% | -$6.51K |
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,671 reduced and 538 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 538 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.